Skip to main content
Top
Published in: Clinical Rheumatology 2/2016

01-02-2016 | Case Based Review

Neuroarthropathy of the foot revealing primary systemic amyloidosis: case report and literature review

Authors: Irina Adriana Andrei, Thierry Kuntzer, Johannes Alexander Lobrinus, Arnaud Jaccard, Pascal Zufferey

Published in: Clinical Rheumatology | Issue 2/2016

Login to get access

Abstract

The aims of this review were to describe the case of a patient with debilitating neuroarthropathy of the ankles and feet and reveal a primary systemic (amyloid light chain, AL) amyloidosis and to review the relevant literature concerning the peripheral neuropathy and neuroarthropathy due to amyloidosis. We will emphasize the diagnostic pitfalls and discuss prognosis and treatments of both the peripheral neuropathy and the arthropathy related to AL amyloidosis. This is a descriptive case report of a patient with neuroarthropathy of the lower limbs due to AL amyloidosis. A review and discussion of relevant literature were conducted, based on a PubMed search from 1973 to December 2013. A 51-year-old female was diagnosed with AL amyloidosis after 20 months of investigation of small painful deformities of the feet. Chronic peripheral neuropathy occurs as a manifestation of AL amyloidosis in 25 % of cases. It may exceptionally be complicated by neuroarthropathy. In this case, the paucity of clinical and electrophysiological signs of the neuropathy delayed the diagnosis, leading to a severe arthropathy. The massive destruction of the joints dominated the clinical and the poor functional outcome. Diagnosis of AL amyloidosis should be considered in the presence of a mild peripheral neuropathy and a distal destructive and painless arthropathy. The two key diagnostic procedures are serum protein electrophoresis and nerve biopsy. Delay in treatment worsens the prognosis.
Literature
2.
go back to reference Gertz MA, Kyle RA (1989) Primary systemic amyloidosis—a diagnostic primer. Mayo Clin Proc Mayo Clin 64(12):1505–1519CrossRefPubMed Gertz MA, Kyle RA (1989) Primary systemic amyloidosis—a diagnostic primer. Mayo Clin Proc Mayo Clin 64(12):1505–1519CrossRefPubMed
5.
go back to reference Rajkumar SV, Gertz MA, Kyle RA (1998) Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy. Am J Med 104(3):232–237CrossRefPubMed Rajkumar SV, Gertz MA, Kyle RA (1998) Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy. Am J Med 104(3):232–237CrossRefPubMed
6.
go back to reference Duston MA, Skinner M, Anderson J, Cohen AS (1989) Peripheral neuropathy as an early marker of AL amyloidosis. Arch Intern Med 149(2):358–360CrossRefPubMed Duston MA, Skinner M, Anderson J, Cohen AS (1989) Peripheral neuropathy as an early marker of AL amyloidosis. Arch Intern Med 149(2):358–360CrossRefPubMed
7.
go back to reference Kyle RA, Greipp PR (1983) Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc Mayo Clin 58(10):665–683PubMed Kyle RA, Greipp PR (1983) Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc Mayo Clin 58(10):665–683PubMed
11.
go back to reference Gherardi R, Zuber M, Viard JP (1988) Dysglobulinemic neuropathies. Rev Neurol 144(6–7):391–408PubMed Gherardi R, Zuber M, Viard JP (1988) Dysglobulinemic neuropathies. Rev Neurol 144(6–7):391–408PubMed
12.
go back to reference Scott RB, Elmore SM, Brackett NC Jr, Harris WO Jr, Still WJ (1973) Neuropathic joint disease (Charcot joints) in Waldenstrom’s macroglobulinemia with amyloidosis. Am J Med 54(4):535–538CrossRefPubMed Scott RB, Elmore SM, Brackett NC Jr, Harris WO Jr, Still WJ (1973) Neuropathic joint disease (Charcot joints) in Waldenstrom’s macroglobulinemia with amyloidosis. Am J Med 54(4):535–538CrossRefPubMed
13.
go back to reference Peitzman SJ, Miller JL, Ortega L, Schumacher HR, Fernandez PC (1976) Charcot arthropathy secondary to amyloid neuropathy. JAMA: J Am Med Assoc 235(13):1345–1347CrossRef Peitzman SJ, Miller JL, Ortega L, Schumacher HR, Fernandez PC (1976) Charcot arthropathy secondary to amyloid neuropathy. JAMA: J Am Med Assoc 235(13):1345–1347CrossRef
14.
go back to reference Pruzanski W, Baron M, Shupak R (1981) Neuroarthropathy (Charcot joints) in familial amyloid polyneuropathy. J Rheumatol 8(3):477–481PubMed Pruzanski W, Baron M, Shupak R (1981) Neuroarthropathy (Charcot joints) in familial amyloid polyneuropathy. J Rheumatol 8(3):477–481PubMed
15.
go back to reference Shiraishi M, Ando Y, Mizuta H, Nakamura E, Takagi K, Ando M (1997) Charcot knee arthropathy with articular amyloid deposition in familial amyloidotic polyneuropathy. Scand J Rheumatol 26(1):61–64CrossRefPubMed Shiraishi M, Ando Y, Mizuta H, Nakamura E, Takagi K, Ando M (1997) Charcot knee arthropathy with articular amyloid deposition in familial amyloidotic polyneuropathy. Scand J Rheumatol 26(1):61–64CrossRefPubMed
16.
go back to reference Duarte C, Serrano PR, Mariano JC (2009) Charcot arthropathy in a patient with hereditary paramyloidosis. Acta Reumatol Port 34(2B):436–437PubMed Duarte C, Serrano PR, Mariano JC (2009) Charcot arthropathy in a patient with hereditary paramyloidosis. Acta Reumatol Port 34(2B):436–437PubMed
18.
go back to reference Lakhanpal S, Li CY, Gertz MA, Kyle RA, Hunder GG (1987) Synovial fluid analysis for diagnosis of amyloid arthropathy. Arthritis Rheum 30(4):419–423CrossRefPubMed Lakhanpal S, Li CY, Gertz MA, Kyle RA, Hunder GG (1987) Synovial fluid analysis for diagnosis of amyloid arthropathy. Arthritis Rheum 30(4):419–423CrossRefPubMed
19.
go back to reference Lithner F (1976) Skin lesions of the legs and feet and skeletal lesions of the feet in familial amyloidosis with polyneuropathy. Acta Med Scand 199(3):197–202PubMed Lithner F (1976) Skin lesions of the legs and feet and skeletal lesions of the feet in familial amyloidosis with polyneuropathy. Acta Med Scand 199(3):197–202PubMed
23.
go back to reference Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, Hartemann A, Game F, Jeffcoate W, Jirkovska A, Jude E, Morbach S, Morrison WB, Pinzur M, Pitocco D, Sanders L (2011) The Charcot foot in diabetes. Diabetes Care 34(9):123-9. doi10.2337/dc11-0844 Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, Hartemann A, Game F, Jeffcoate W, Jirkovska A, Jude E, Morbach S, Morrison WB, Pinzur M, Pitocco D, Sanders L (2011) The Charcot foot in diabetes. Diabetes Care 34(9):123-9. doi10.​2337/​dc11-0844
Metadata
Title
Neuroarthropathy of the foot revealing primary systemic amyloidosis: case report and literature review
Authors
Irina Adriana Andrei
Thierry Kuntzer
Johannes Alexander Lobrinus
Arnaud Jaccard
Pascal Zufferey
Publication date
01-02-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 2/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2782-0

Other articles of this Issue 2/2016

Clinical Rheumatology 2/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.